Transdermal Diagnostics Ltd

🗓 Founded 2021👥 10 employees💰 Last funded Aug 2022
Transdermal Diagnostics, a MedTech venture spin-out from the University of Bath, is pioneering the development of bio-wearables with a primary focus on enhancing the prevention, diagnosis, and management of chronic conditions. Our revolutionary technology enables non-invasive, continuous co-monitoring of health biomarkers to catalyze a transformative shift in patient care and elevate overall quality of life. Presently, we are in the process of creating the worlds first 100% needle-free (and pain-free) CGM. This innovative device is designed to empower individuals living with diabetes, pre-diabetes, and obesity by providing them with personalized biological insights and enabling them to make informed decisions for a healthier lifestyle.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Transdermal Diagnostics Ltd?
Transdermal Diagnostics Ltd has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Transdermal Diagnostics Ltd last raise funding?
The most recent investment in Transdermal Diagnostics Ltd recorded on gritt.io was in August 2022.
When was Transdermal Diagnostics Ltd founded?
Transdermal Diagnostics Ltd was founded in 2021.
What industry is Transdermal Diagnostics Ltd in?
Transdermal Diagnostics Ltd operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.